In December 2005, Eli Lilly and Corporation agreed to plead responsible and pay back $36 million in connection with the unlawful marketing of your drug.[264] Product sales Associates had been skilled to advertise Evista for breast cancer and heart problems, to prompt or bait thoughts by Medical